Zentalis Pharmaceuticals
ZNTL
ZNTL
107 hedge funds and large institutions have $1.94B invested in Zentalis Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11.65% more ownership
Funds ownership: 80.2% → 91.85% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
107
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$168M | |
| 2 | +$68.3M | |
| 3 | +$63M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$37.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$12M |
Top Sellers
| 1 | -$74.4M | |
| 2 | -$32.4M | |
| 3 | -$18.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.65M |
| 5 |
MC
Mayo Clinic
Rochester,
Minnesota
|
-$4.17M |